[ad_1]
The pharmacovigilance system received notification of two cases of reactions to the vaccine against covid-19, which, however, “do not have the same clinical pattern as those evaluated,” Infarmed assumes this Sunday. Therefore, Portugal will continue to administer the AstraZeneca vaccine, but doctors will be asked to report all suspected adverse reactions after vaccination.
“Health professionals who suspect adverse reactions after vaccination against covid-19 should immediately report these reactions to the National Pharmacovigilance System,” requests the National Medicines Authority (Infarmed) and the General Directorate of Health (DGS) in a joint statement issued this Sunday Night.
Ireland today temporarily suspended the administration of the AstraZeneca vaccine, becoming the 10th European country to make the decision. “The notified cases are being evaluated by the Safety Committee, PRAC, of the European Medicines Evaluation Agency (EMA), and a conclusion is expected next week”, Infarmed and DGS underline to justify that for now Portugal maintains the decision Continue giving the vaccine.
“This issue continues to be monitored by national health authorities, through their participation in the evaluation that is being carried out at European level together with European counterparts, that is, in the meetings that will take place next week. Any new information will be available immediately, “he concludes.
The decision to stop the AstraZeneca vaccine was made after severe cases of blood clotting were detected after vaccination. Austria and Italy even recorded deaths after vaccination. This Saturday DGS and Infarmed made sure that the suspicious lots were not distributed in Portugal.
In the statement, DGS and Infarmed recall that the number of cases of thromboembolism reported in the vaccinated population in the European Union (around 5 million doses) and in the United Kingdom (around 11 million doses) “is not still higher. to that observed in the general population “.
[ad_2]
